SCHEMBL26158581

SCHEMBL26158581

Cc1cc(NC(=O)c2cc(O)c(S(=O)(=O)O)cc2O)cc(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 2/20 0.44
▸ TMPRSS4 Q9NRS4 2/20 0.44
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ POLB P06746 3/20 0.40
▸ TPMT P51580 1/20 0.39
▸ FABP1 P07148 1/20 0.39
▸ P2RY14 Q15391 1/20 0.39
▸ HCAR1 Q9BXC0 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ RARA P10276 1/20 0.38
▸ RARG P13631 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23796878 0.91 PKM (0.46) P2RX1TMPRSS4MEN1KMT2APOLB
SCHEMBL23796605 0.91 KMT2A (0.43) MEN1KMT2APOLBL3MBTL1PKM
SCHEMBL26158577 0.85 P2RX1 (0.51) P2RX1TMPRSS4MEN1KMT2APOLB
SCHEMBL23796653 0.82 HSD17B10 (0.37) P2RX1MEN1KMT2APOLBL3MBTL1
SCHEMBL30030743 0.82 HSD17B10 (0.37) P2RX1MEN1KMT2APOLBL3MBTL1
SCHEMBL23796665 0.82 KMT2A (0.48) P2RX1MEN1KMT2APOLBNPC1
SCHEMBL26158582 0.81 HCAR1 (0.44) P2RX1TMPRSS4MEN1KMT2APOLB
SCHEMBL30031087 0.81 KMT2A (0.51) P2RX1MEN1KMT2ANPC1RAB9A
SCHEMBL23796964 0.81 KMT2A (0.51) P2RX1MEN1KMT2ANPC1RAB9A
SCHEMBL30031684 0.80 KDM4E (0.44) MEN1KMT2APOLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 — — US disclosed
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS HRH4, NCOA4, HRH3 P2RX1 2311/4885TMPRSS4 805/4885MEN1 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback